Evaluate Different Extended-release (ER) Tablets/Capsules of AZD1305
NCT00689403
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
AZD1305
DRUG:
AZD1305
Sponsor
AstraZeneca